NFKBIE as a prognostic biomarker and therapeutic target for GBM: role in Hedgehog signaling activation
Abstract Glioblastoma (GBM), as one of the most common and aggressive primary brain tumors, pose significant challenges in diagnosis and treatment, highlighting the urgent need for the identification of novel biomarkers, NFKBIE, which may play a critical role in tumor progression, immune modulation,...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2025-10-01
|
| Series: | BMC Cancer |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12885-025-14775-9 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|